DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,944 | -36.7% | 27,031 | -31.0% | 0.02% | -33.3% |
| Q2 2023 | $9,396 | -31.9% | 39,149 | -28.5% | 0.03% | -34.8% |
| Q1 2023 | $13,792 | -3.3% | 54,723 | +1.8% | 0.05% | -8.0% |
| Q4 2022 | $14,265 | -99.9% | 53,746 | -1.6% | 0.05% | -7.4% |
| Q3 2022 | $14,103,000 | +7.8% | 54,602 | +5.8% | 0.05% | +17.4% |
| Q2 2022 | $13,078,000 | +7.1% | 51,587 | +23.9% | 0.05% | +17.9% |
| Q1 2022 | $12,210,000 | -1.8% | 41,627 | +10.2% | 0.04% | +8.3% |
| Q4 2021 | $12,429,000 | +27.7% | 37,778 | +18.2% | 0.04% | +12.5% |
| Q3 2021 | $9,734,000 | -18.6% | 31,974 | -28.2% | 0.03% | -3.0% |
| Q2 2021 | $11,952,000 | +0.1% | 44,536 | -16.0% | 0.03% | -5.7% |
| Q1 2021 | $11,939,000 | +5.1% | 53,044 | +3.7% | 0.04% | -2.8% |
| Q4 2020 | $11,362,000 | +28.4% | 51,146 | +24.4% | 0.04% | -5.3% |
| Q3 2020 | $8,852,000 | +15.9% | 41,107 | -4.8% | 0.04% | +8.6% |
| Q2 2020 | $7,637,000 | +103.9% | 43,190 | +59.6% | 0.04% | +84.2% |
| Q1 2020 | $3,745,000 | -46.9% | 27,054 | -41.2% | 0.02% | -34.5% |
| Q4 2019 | $7,056,000 | -68.9% | 45,973 | -70.7% | 0.03% | -71.3% |
| Q3 2019 | $22,685,000 | +37.6% | 157,062 | +36.2% | 0.10% | +38.4% |
| Q2 2019 | $16,485,000 | -0.6% | 115,341 | -8.2% | 0.07% | -3.9% |
| Q1 2019 | $16,582,000 | +9.2% | 125,602 | -14.7% | 0.08% | -2.6% |
| Q4 2018 | $15,187,000 | -13.8% | 147,275 | -9.2% | 0.08% | +2.6% |
| Q3 2018 | $17,628,000 | -66.0% | 162,228 | -69.1% | 0.08% | -66.5% |
| Q2 2018 | $51,835,000 | +2246.5% | 525,287 | +2228.2% | 0.23% | +2422.2% |
| Q1 2018 | $2,209,000 | +18.7% | 22,562 | +12.5% | 0.01% | +12.5% |
| Q4 2017 | $1,861,000 | -78.4% | 20,052 | -80.0% | 0.01% | -80.5% |
| Q3 2017 | $8,596,000 | -59.4% | 100,208 | -60.0% | 0.04% | -54.4% |
| Q2 2017 | $21,151,000 | +109.8% | 250,636 | +112.6% | 0.09% | +181.2% |
| Q1 2017 | $10,081,000 | +260.7% | 117,867 | +228.3% | 0.03% | +220.0% |
| Q4 2016 | $2,795,000 | +50.3% | 35,903 | +51.4% | 0.01% | +25.0% |
| Q3 2016 | $1,859,000 | +53.6% | 23,717 | +50.0% | 0.01% | +60.0% |
| Q2 2016 | $1,210,000 | -15.7% | 15,811 | +4.4% | 0.01% | -28.6% |
| Q1 2016 | $1,436,000 | -59.2% | 15,139 | -60.1% | 0.01% | -61.1% |
| Q4 2015 | $3,520,000 | +158.3% | 37,902 | +137.0% | 0.02% | +157.1% |
| Q3 2015 | $1,363,000 | +1.2% | 15,993 | +1.6% | 0.01% | +16.7% |
| Q2 2015 | $1,347,000 | +14.8% | 15,736 | +13.9% | 0.01% | +20.0% |
| Q1 2015 | $1,173,000 | -30.7% | 13,817 | -30.0% | 0.01% | -16.7% |
| Q4 2014 | $1,692,000 | +5.8% | 19,745 | -6.2% | 0.01% | 0.0% |
| Q3 2014 | $1,600,000 | -4.1% | 21,056 | -0.7% | 0.01% | 0.0% |
| Q2 2014 | $1,669,000 | -9.7% | 21,196 | -14.0% | 0.01% | -14.3% |
| Q1 2014 | $1,849,000 | -16.6% | 24,654 | -14.2% | 0.01% | -22.2% |
| Q4 2013 | $2,218,000 | +45.1% | 28,731 | +30.2% | 0.01% | +50.0% |
| Q3 2013 | $1,529,000 | +42.0% | 22,059 | +29.7% | 0.01% | +20.0% |
| Q2 2013 | $1,077,000 | – | 17,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |